TRAJENTA®: The only approved DPP4i that does not require dose reduction based on kidney function1-5.


Required DPP4i dose with declining kidney function, as defined by SmPC1-5

TRAJENTA®: The only approved DPP4i that does not require dose reduction based on kidney function

BID: Twice daily; CrCl: Creatinine clearance; ESRD: End-stage renal disease; GFR: Glomerular filtration rate; KI: Kidney impairment; QD: Once daily.

See DPP4i dosing chart including the single-pill combination JENTADUETO®